Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus
Frontiers in Reproductive Health · 09.05.2024 · 6
DOI: 10.3389/frph.2024.1397446 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Frontiers in Reproductive Health, online erschienen am 09.05.2024. Verfasst von Saghar Salehpour und 8 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, Shahid Beheshti University of Medical Science, Tehran, Iran. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity.
Methods
Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements.
Results
Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3′) obtained an 83% agreement.
Discussion
The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics and Gynecology Department, Shahid Beheshti University of Medical Science, Tehran, Iran.
- Obstetrics and Gynecology Department, Tehran Medical Science University, Tehran, Iran.
- Department of Gynecology and Obstetrics, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
- Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran.
- Armaghan Infertility Center, Mashhad Medical Science University, Mashhad, Iran.
Zitieren
APA
Salehpour, S., Aleyasin, A., Moini, A., Mousavifar, N., Mohammadhossein, N., Abdollahi Fard, S., Marzie, S., Mohammadzadeh, M., & Fischer, R. (2024). Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus. Frontiers in Reproductive Health, 6. https://doi.org/10.3389/frph.2024.1397446
Vancouver
Salehpour S, Aleyasin A, Moini A, Mousavifar N, Mohammadhossein N, Abdollahi Fard S, et al. Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus. Frontiers in Reproductive Health. 2024;6. doi:10.3389/frph.2024.1397446
BibTeX
@article{Salehpour2024,
author = {Salehpour, Saghar and Aleyasin, Ashraf and Moini, Ashraf and Mousavifar, Nezhat and Mohammadhossein, Nasresfahani and Abdollahi Fard, Sedighe and Marzie, Sanuiefarimani and Mohammadzadeh, Mahboubeh and Fischer, Robert},
title = {Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus},
journal = {Frontiers in Reproductive Health},
year = {2024},
volume = {6},
doi = {10.3389/frph.2024.1397446}
}
EUVIMED